-
L287872-10mgSelective β3antagonist.
-
L287872-1mgSelective β3antagonist.
-
L287872-25mgSelective β3antagonist.
-
L287872-50mgSelective β3antagonist.
-
L287872-5mgSelective β3antagonist.
-
-
-
L288431-100mgProduct description:L755507 is a derivative of 4-acylaminobenzenesulfonamide.Application:L755507 has been shown to enhance CRISPR genome editing efficiency. Biochemical mechanism:L755507 is a potent β3-adrenergic receptor partial agonist with an
-
L288431-10mgProduct description:L755507 is a derivative of 4-acylaminobenzenesulfonamide.Application:L755507 has been shown to enhance CRISPR genome editing efficiency. Biochemical mechanism:L755507 is a potent β3-adrenergic receptor partial agonist with an
-
L288431-25mgProduct description:L755507 is a derivative of 4-acylaminobenzenesulfonamide.Application:L755507 has been shown to enhance CRISPR genome editing efficiency. Biochemical mechanism:L755507 is a potent β3-adrenergic receptor partial agonist with an
-
L288431-50mgProduct description:L755507 is a derivative of 4-acylaminobenzenesulfonamide.Application:L755507 has been shown to enhance CRISPR genome editing efficiency. Biochemical mechanism:L755507 is a potent β3-adrenergic receptor partial agonist with an
-
L288431-5mgProduct description:L755507 is a derivative of 4-acylaminobenzenesulfonamide.Application:L755507 has been shown to enhance CRISPR genome editing efficiency. Biochemical mechanism:L755507 is a potent β3-adrenergic receptor partial agonist with an